FK
Faisal Khurshid Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.78B
| $102.12 | $102 |
0%
downside
| Outperform | 1 month ago |
|
2
AbCellera Biologics
ABCL
$1.26B
| $4.22 | $5 |
18%
upside
| Outperform | 2 months ago |
|
3
Spyre Therapeutics
SYRE
$1.03B
| $17 | $45 |
165%
upside
| Outperform | 5 months ago |
|
4
Nurix Therapeutics
NRIX
$758M
| $9.91 | $16 |
61%
upside
| Market Perform | 5 months ago |
|
|
ATYR
5
aTyr Pharma
ATYR
$550M
| $5.61 | $16 |
185%
upside
| Outperform | 6 months ago |
|
6
Kymera Therapeutics
KYMR
$3.11B
| $43.51 | $60 |
38%
upside
| Outperform | 8 months ago |
|
7
ANI Pharmaceuticals
ANIP
$2.07B
| $95.35 | $80 |
16%
downside
| Outperform | 9 months ago |
|
8
Trevi Therapeutics
TRVI
$854M
| $7.01 | $7 |
0%
downside
| Outperform | 1 year ago |
|
|
PRTC
9
PureTech Health
PRTC
$392M
| $16.23 | $45 |
177%
upside
| Outperform | 1 year ago |
|
10
Galapagos
GLPG
$2.2B
| $33.36 | $24 |
28%
downside
| Market Perform | 1 year ago |
|
11
Geron
GERN
$893M
| $1.40 | $7 |
400%
upside
| Outperform | 1 year ago |
|
12
MannKind Corp
MNKD
$1.7B
| $5.54 | $8 |
44%
upside
| Outperform | 1 year ago |
|